Overview

Aripiprazole in Late Life Bipolar Disorder

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to analyze the effectiveness and tolerability of a new medication, aripiprazole (Abilify), in individuals age 50 years and older who have bipolar disorder (manic-depressive illness).

Phase:

Phase 4

Details

Lead Sponsor:

University Hospitals Cleveland Medical Center

Collaborator:

Bristol-Myers Squibb

Treatments:

Aripiprazole